A detailed history of Hancock Whitney Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Hancock Whitney Corp holds 51,628 shares of JNJ stock, worth $8.09 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
51,628
Previous 53,240 3.03%
Holding current value
$8.09 Million
Previous $8.42 Million 10.41%
% of portfolio
0.26%
Previous 0.29%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $232,740 - $254,341
-1,612 Reduced 3.03%
51,628 $7.55 Million
Q1 2024

May 16, 2024

SELL
$155.22 - $162.74 $344,898 - $361,608
-2,222 Reduced 4.01%
53,240 $8.42 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $218,254 - $238,161
-1,499 Reduced 2.63%
55,462 $8.69 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $268,357 - $300,629
-1,723 Reduced 2.94%
56,961 $8.87 Million
Q2 2023

Nov 13, 2023

SELL
$154.35 - $166.11 $743,349 - $799,985
-4,816 Reduced 7.58%
58,684 $9.71 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $743,349 - $799,985
-4,816 Reduced 7.58%
58,684 $9.71 Million
Q1 2023

Nov 13, 2023

SELL
$151.05 - $180.26 $181,411 - $216,492
-1,201 Reduced 1.86%
63,500 $9.84 Million
Q1 2023

May 16, 2023

SELL
$151.05 - $180.26 $181,411 - $216,492
-1,201 Reduced 1.86%
63,500 $9.84 Million
Q4 2022

Nov 13, 2023

BUY
$160.2 - $179.79 $963,923 - $1.08 Million
6,017 Added 10.25%
64,701 $11.4 Million
Q4 2022

Feb 03, 2023

SELL
$160.2 - $179.79 $183,589 - $206,039
-1,146 Reduced 1.74%
64,701 $11.4 Million
Q3 2022

Oct 26, 2022

SELL
$161.33 - $179.52 $38,396 - $42,725
-238 Reduced 0.36%
65,847 $10.8 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $110,669 - $122,394
658 Added 1.01%
66,085 $11.7 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $29,255 - $33,224
-185 Reduced 0.28%
65,427 $11.6 Million
Q4 2021

Jan 25, 2022

BUY
$155.93 - $173.01 $32,901 - $36,505
211 Added 0.32%
65,612 $11.2 Million
Q3 2021

Nov 04, 2021

SELL
$161.5 - $179.47 $449,131 - $499,106
-2,781 Reduced 4.08%
65,401 $10.6 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $127,743 - $137,027
801 Added 1.19%
68,182 $11.2 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $375,327 - $418,016
-2,452 Reduced 3.51%
67,381 $11.1 Million
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $481,256 - $552,403
-3,510 Reduced 4.79%
69,833 $11 Million
Q3 2020

Nov 05, 2020

SELL
$140.38 - $153.83 $48,431 - $53,071
-345 Reduced 0.47%
73,343 $10.9 Million
Q2 2020

Jul 30, 2020

SELL
$128.81 - $155.51 $193,086 - $233,109
-1,499 Reduced 1.99%
73,688 $10.4 Million
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $710,629 - $984,612
6,394 Added 9.29%
75,187 $9.86 Million
Q4 2019

Feb 06, 2020

SELL
$127.5 - $146.44 $179,137 - $205,748
-1,405 Reduced 2.0%
68,793 $10 Million
Q3 2019

Oct 29, 2019

BUY
$126.95 - $142.14 $27,167 - $30,417
214 Added 0.31%
70,198 $9.08 Million
Q2 2019

Aug 29, 2019

BUY
$131.15 - $144.24 $261,119 - $287,181
1,991 Added 2.93%
69,984 $9.75 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $6.97 Million - $7.75 Million
-55,422 Reduced 44.91%
67,993 $9.51 Million
Q4 2018

Feb 15, 2019

BUY
$122.84 - $147.84 $7.84 Million - $9.43 Million
63,791 Added 106.99%
123,415 $15.9 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $6.68 Million - $7.85 Million
54,930 Added 1170.22%
59,624 $8.24 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $12.4 Million - $13.7 Million
-103,777 Reduced 95.67%
4,694 $570,000
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $421,712 - $499,379
-3,371 Reduced 3.01%
108,471 $13.9 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $231,734 - $253,632
-1,766 Reduced 1.55%
111,842 $15.6 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $418,835 - $437,954
-3,235 Reduced 2.77%
113,608 $14.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
116,843
116,843 $15.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.